$3.180
-0.010 (-0.31%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ESPR por análisis de gráficos similares
Alphio's ESPR stock price prediction model matches the current Esperion Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.22 (+1.24%). The 1-week path is $3.31 (+4.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Esperion Therapeutics Inc?
ESPR is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock is effectively priced at the acquisition level of $3.16, leaving very limited upside from the current $3.17 close. Since the investor is impatient and does not want to wait for a better entry, the best direct conclusion is to avoid buying new shares now and wait for a clearer catalyst or a better risk/reward setup. If already holding, this is more of a hold than an aggressive buy.
ESPR cerró en $3.18 el Friday, tras bajar -0.31%
Esperion Therapeutics Inc (ESPR) last closed at $3.18, losing -0.31%. These facts feed the 1-day and 1-week ESPR price prediction above.
Consenso de analistas
Esperion Therapeutics Inc (ESPR): 9 comprar, 2 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Esperion Therapeutics Inc (ESPR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ESPR, ordenadas por similitud.
Análisis de estacionalidad de ESPR
Historically the probability of a positive August return for ESPR is 4.65%. December offers the highest probability of a positive month at 67.44%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ESPR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.79 | $1.01 | $1.03 | -68.16% |
| Sep 2026 | $0.96 | $1.02 | $1.18 | -67.83% |
| Oct 2026 | $0.96 | $1.27 | $1.29 | -60.04% |
| Nov 2026 | $1.01 | $1.03 | $1.19 | -67.61% |
| Dec 2026 | $0.86 | $1.21 | $1.26 | -62.09% |
En 2026, se proyecta que Esperion Therapeutics Inc (ESPR) oscile entre $0.79 y $1.29.
Previsión mensual de Esperion Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Esperion Therapeutics Inc promedie $1.01, con un mínimo de $0.79 y un máximo de $1.03.
En Sep de 2026, se proyecta que Esperion Therapeutics Inc promedie $1.02, con un mínimo de $0.96 y un máximo de $1.18.
En Oct de 2026, se proyecta que Esperion Therapeutics Inc promedie $1.27, con un mínimo de $0.96 y un máximo de $1.29.
En Nov de 2026, se proyecta que Esperion Therapeutics Inc promedie $1.03, con un mínimo de $1.01 y un máximo de $1.19.
En Dec de 2026, se proyecta que Esperion Therapeutics Inc promedie $1.21, con un mínimo de $0.86 y un máximo de $1.26.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.